When analysing all AD samples, tau fragments resolving as a smear were only detectable in the high molecular weight fractions when revealed by MTBR-recognising 7G6 antibody but not with the mid-domain HT7 antibody. This evidence concerns the gene MAPT and Alzheimer disease.